{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T21:05:37Z","timestamp":1785618337204,"version":"3.56.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MEXT-Supported Program for the Strategic Research Foundation at Private Universities","award":["S1411037"],"award-info":[{"award-number":["S1411037"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.neuropharm.2018.06.020","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T19:30:04Z","timestamp":1529350204000},"page":"232-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice"],"prefix":"10.1016","volume":"138","author":[{"given":"Fumiko","family":"Sekiguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tomochika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumire","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamato","family":"Horaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Ichii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nene","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadatoshi","family":"Tanino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy Du","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyako","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3163-807X","authenticated-orcid":false,"given":"Atsufumi","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.06.020_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuroscience.2016.03.029","article-title":"Translational neuropathic pain research: a clinical perspective","volume":"338","author":"Bouhassira","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/bph.13962","article-title":"Sodium channels and pain: from toxins to therapies","volume":"175","author":"Cardoso","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J.\u00a0Neurosci. Meth."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib4","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1523\/JNEUROSCI.22-16-06856.2002","article-title":"Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line","volume":"22","author":"Chemin","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pain.2012.10.023","article-title":"State-dependent properties of a new T-type calcium channel blocker enhance CaV3.2 selectivity and support analgesic effects","volume":"154","author":"Francois","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib6","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00424-015-1725-1","article-title":"Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels","volume":"467","author":"Gadotti","year":"2015","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnbeh.2014.00092","article-title":"T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants","volume":"8","author":"Gangarossa","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib8","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","article-title":"The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity","volume":"83","author":"Garcia-Caballero","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib9","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1152\/jn.01031.2007","article-title":"Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve","volume":"99","author":"Jagodic","year":"2008","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/16040","article-title":"Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity","volume":"2","author":"Ji","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pain.2007.01.026","article-title":"Hydrogen sulfide as a novel nociceptive messenger","volume":"132","author":"Kawabata","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11064-007-9334-9","article-title":"Enhancement of sodium current in NG108-15 cells during neural differentiation is mainly due to an increase in NaV1.7 expression","volume":"32","author":"Kawaguchi","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0032-1328330","article-title":"Hop extracts and hop substances in treatment of menopausal complaints","volume":"79","author":"Keiler","year":"2013","journal-title":"Planta Med."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pain.2010.02.025","article-title":"Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation","volume":"149","author":"Kiguchi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.110.171058","article-title":"In\u00a0vitro characterization of T-type calcium channel antagonist TTA-A2 and in\u00a0vivo effects on arousal in mice","volume":"335","author":"Kraus","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib16","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.2337\/db08-1763","article-title":"Selective T-type calcium channel blockade alleviates hyperalgesia in ob\/ob mice","volume":"58","author":"Latham","year":"2009","journal-title":"Diabetes"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2018.06.020_bib17","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/jns.12080_2","article-title":"Z944: a first in class T-type calcium channel modulator for the treatment of pain","volume":"19","author":"Lee","year":"2014","journal-title":"J.\u00a0Peripher. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pain.2008.12.021","article-title":"Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels","volume":"142","author":"Maeda","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib19","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1073\/pnas.1100869108","article-title":"T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome","volume":"108","author":"Marger","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuroscience.2011.02.044","article-title":"Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels","volume":"181","author":"Matsunami","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/gut.2007.144543","article-title":"Luminal hydrogen sulfide plays a pronociceptive role in mouse colon","volume":"58","author":"Matsunami","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1476-5381.2012.02060.x","article-title":"Involvement of the endogenous hydrogen sulfide\/Cav3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice","volume":"167","author":"Matsunami","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pain.2009.06.012","article-title":"In\u00a0vivo silencing of the Cav3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy","volume":"145","author":"Messinger","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.pbb.2010.11.014","article-title":"Effects of T-type calcium channel blockers on a parkinsonian tremor model in rats","volume":"97","author":"Miwa","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1471-4159.2008.05808.x","article-title":"Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels","volume":"108","author":"Nagasawa","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/gut.2008.151910","article-title":"Hydrogen sulfide as a novel mediator for pancreatic pain in rodents","volume":"58","author":"Nishimura","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1476-5381.2012.01835.x","article-title":"Topical application of disodium isostearyl 2-O-L-ascorbyl phosphate, an amphiphilic ascorbic acid derivative, reduces neuropathic hyperalgesia in rats","volume":"166","author":"Okubo","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib28","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/j.1476-5381.2012.01886.x","article-title":"Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice","volume":"166","author":"Okubo","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2011.05.004","article-title":"Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats","volume":"188","author":"Okubo","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib30","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.2337\/db13-0813","article-title":"Reversal of neuropathic pain in diabetes by targeting glycosylation of Cav3.2 T-type calcium channels","volume":"62","author":"Orestes","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib31","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1021\/jf050448p","article-title":"Comparison of the in\u00a0vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense)","volume":"53","author":"Overk","year":"2005","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tox.2017.11.012","article-title":"Zinc deficiency promotes cystitis-related bladder pain by enhancing function and expression of Cav3.2 in mice","volume":"393","author":"Ozaki","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib33","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/jf0509714","article-title":"Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin","volume":"53","author":"Possemiers","year":"2005","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib34","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1021\/jm060692n","article-title":"Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist\/antagonist activity profiles for estrogen receptors alpha and beta","volume":"49","author":"Roelens","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02973946","article-title":"Determination of isoprenyl and lavandulyl positions of flavonoids fro msophora flavescens by NMR experiment","volume":"20","author":"Ryu","year":"1997","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pain.2009.09.003","article-title":"Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia","volume":"147","author":"Sakurai","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1254\/jphs.13R05CP","article-title":"T-type calcium channels: functional regulation and implication in pain signaling","volume":"122","author":"Sekiguchi","year":"2013","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbrc.2014.01.185","article-title":"Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells","volume":"445","author":"Sekiguchi","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1476-5381.2012.02174.x","article-title":"AKAP-dependent sensitization of Cav3.2 channels via the EP4 receptor\/cAMP pathway mediates PGE2-induced mechanical hyperalgesia","volume":"168","author":"Sekiguchi","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib40","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/j.pain.0000000000000565","article-title":"Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain","volume":"157","author":"Sekiguchi","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A\u00a0novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib42","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/j.pain.0000000000000249","article-title":"Effects of a T-type calcium channel blocker, ABT-639, on spontaneous activity in C-nociceptors in patients with painful diabetic neuropathy: a randomized controlled trial","volume":"156","author":"Serra","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib43","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/bph.13906","article-title":"Recent advances in the development of T-type calcium channel blockers for pain intervention","volume":"175","author":"Snutch","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pain.2010.04.022","article-title":"Upregulation of Cav3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain","volume":"150","author":"Takahashi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/adsc.200600454","article-title":"Selective C-6 prenylation of flavonoids via europium (III)-catalyzed claisen rearrangement and cross-metathesis","volume":"349","author":"Tischer","year":"2007","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1476-5381.2011.01256.x","article-title":"T-type voltage-gated calcium channels as targets for the development of novel pain therapies","volume":"163","author":"Todorovic","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib47","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00424-012-1211-y","article-title":"Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling","volume":"465","author":"Todorovic","year":"2013","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003120","article-title":"T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures","volume":"4","author":"Tringham","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1254\/jphs.12086SC","article-title":"Colonic hydrogen sulfide-induced visceral pain and referred hyperalgesia involve activation of both Cav3.2 and TRPA1 channels in mice","volume":"119","author":"Tsubota-Matsunami","year":"2012","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib50","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.bbamem.2012.07.031","article-title":"Control of low-threshold exocytosis by T-type calcium channels","volume":"1828","author":"Weiss","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib51","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1248\/yakushi1947.105.8_736","article-title":"Studies on the constituents of Sophora flavescens ait. III","volume":"105","author":"Wu","year":"1985","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib52","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2018.06.020_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1744-8069-8-55","article-title":"Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice","volume":"8","author":"Zhao","year":"2012","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2018.06.020_bib54","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/j.pain.0000000000000263","article-title":"A\u00a0randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain","volume":"156","author":"Ziegler","year":"2015","journal-title":"Pain"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T05:10:06Z","timestamp":1561353006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818303095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":54,"alternative-id":["S0028390818303095"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.06.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}